Spread and Course of COVID-19 Infections
NCT04377724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2910
Last updated 2023-02-23
Summary
The overall goal is to study the immune response to SARS-CoV-2 infection over the period of one year in the blood of a representative cohort of ETH students/employees.
Conditions
- Covid-19
- Virus Disease
Sponsors & Collaborators
-
Goldhahn Jörg
lead OTHER
Principal Investigators
-
Jörg Goldhahn, MD · ETH Zurich
-
Susanne Ulbrich, Prof. Dr. · ETH Zurich
-
Markus Stoffel, Prof. Dr. · ETH Zurich
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-27
- Primary Completion
- 2022-02-04
- Completion
- 2022-02-04
Countries
- Switzerland
Study Locations
More Related Trials
-
Testing for COVID-19 Infection in Asymptomatic Persons
NCT04345510 ·Status: COMPLETED
-
Precision Immunology to Determine the Immune Response in Patients With COVID-19
NCT04360733 ·Status: UNKNOWN
-
Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
NCT04581135 ·Status: COMPLETED
-
COVID-19 Contact Study by Antigen Detection Test
NCT04745533 ·Status: WITHDRAWN
-
Cohort of the Specialist Network Infectious Diseases
NCT06879184 ·Status: NOT_YET_RECRUITING
-
Understanding COVID-19
NCT04329546 ·Status: COMPLETED
-
Health Professional Exposure Assessment to Covid-19
NCT04429724 ·Status: COMPLETED ·Phase: NA
-
Characterizing the Immune Response and Neuronal Damage in COVID-19
NCT04510012 ·Status: COMPLETED
-
Immunophenotyping Assessment in a COVID-19 Cohort
NCT04378777 ·Status: COMPLETED
-
Detection of Anti-COVID-19 Antibody Levels in an Hospital Population
NCT04387929 ·Status: UNKNOWN
-
COVID-19 Epidemic Response Study
NCT04357496 ·Status: WITHDRAWN
-
Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19
NCT04346329 ·Status: WITHDRAWN ·Phase: PHASE3
-
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 ·Status: COMPLETED
-
Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.
NCT04347694 ·Status: UNKNOWN
-
Immunological Characteristics of COVID-19 Patients
NCT04679428 ·Status: UNKNOWN
-
Outcomes in Hospitalized Older Patients With COVID-19
NCT04385212 ·Status: COMPLETED
-
Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19)
NCT04425759 ·Status: UNKNOWN
-
An Observational Study of Patients With Coronavirus Disease 2019
NCT04331886 ·Status: COMPLETED
-
Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19
NCT04373148 ·Status: COMPLETED
-
Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome
NCT04346017 ·Status: COMPLETED ·Phase: NA
-
Dynamic Evaluation of COVID-19 Diagnostic Tests
NCT04337996 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Immune Response for COVID-19
NCT04348422 ·Status: COMPLETED
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER
NCT04341142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong
NCT04325919 ·Status: UNKNOWN